I migliori medici per il trattamento di Cancro gastrico stadio 2 - TOP-15 medici

Il Prof. Merimsky guida l'Unità di Oncologia dei Tessuti Molli e delle Ossa presso il Sourasky Medical Center, con decenni di esperienza specializzata nel cancro dello stomaco.

• Professore associato di Oncologia all'Università di Tel Aviv
• Formazione di fellowship presso l'Institut Gustave Roussy di Parigi
• Membro della Faculty Sarcoma di ESMO e di ASCO
• Ha pubblicato ampiamente sui risultati del trattamento del cancro

Il Dr. Pelles Sharon è specializzato nella chirurgia del cancro allo stomaco presso il Sourasky Medical Center (Ichilov), con expertise in trattamenti avanzati come HIPEC e immunoterapia.

• Esegue complesse chirurgie del cancro allo stomaco, inclusi procedure di Whipple
• Pioniera della Chemioterapia Intraperitoneale Ipertermica (HIPEC) per casi aggressivi
• Offre opzioni di immunoterapia come Keytruda per trattamenti mirati
• Dirige la ricerca clinica sulle attitudini dei pazienti oncologici verso gli studi clinici

Prof. Nadir Arber is a top gastroenterologist from Israel with over 30 years of experience in the field. He is specialized in the prevention, early diagnostics, and treatment of GI cancers, with education from Hebrew University, Tel Aviv University, and NewYork-Presbyterian Center. He has written over 300 papers on his research and is a member of numerous organizations in the field.

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Alla guida dell'Iniziativa Nazionale Israeliana di Medicina Genomica – il Dr. Raphael è specializzato nel profilo genomico avanzato per il trattamento personalizzato del cancro allo stomaco presso il Sourasky Medical Center.

• Docente Anziano in Oncologia Medica con un'ampia esperienza nella conduzione di trial clinici
• Esperto in biopsie liquide e profilazione genomica completa
• Investigatore Principale per numerosi studi innovativi su immunoterapia e chemioterapia
• Membro di ESMO, IASLC e altre prestigiose società oncologiche
• Vincitore di numerosi premi per l'eccellenza didattica e alla ricerca

Il Dr. Wolf dirige la Divisione di Oncologia Medica presso il Centro Medico Sourasky, un importante ospedale universitario israeliano con alta competenza nella cura del cancro complesso.

• Specializzato in oncologia medica e medicina interna
• Fluente in inglese per pazienti internazionali
• Ha conseguito una laurea presso l'Università Ben Gurion
• Ha acquisito vasta esperienza clinica nelle Unità Mediche dell'Esercito

Dr. Irina Stepfansky is an oncologist and internal medicine specialist at Sourasky Medical Center. She has more than 25 years of clinical experience. Since 2015, she has directed the Oncology Hospitalization department. Dr. Stepfansky earned her medical degree from Grodno University in Belarus. She completed advanced oncology training at Tel Aviv Medical Center.

Dr. Stepfansky has been licensed in Israel since 2000. She has led and participated in many phase I-III oncology clinical trials. Her work has helped improve cancer care and patient outcomes. She is recognized for her expertise in both internal medicine and oncology. Dr. Stepfansky has a strong record in research and clinical leadership.

Professional Profile

Dr. Almog Ben-Yaacov is a highly experienced surgeon specializing in general and oncological surgery. He graduated with honors from Semmelweis University Medical School in 2006. Following graduation, he completed two years of training in cardiac surgery, after which he continued with six additional years of advanced training in general surgery.

He currently serves as a senior surgeon at Sheba Medical Center. His clinical focus includes cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS + HIPEC), as well as the management of gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, Dr. Ben-Yaacov has performed over 200 HIPEC procedures.

Advanced Training

Dr. Ben-Yaacov has completed multiple specialized international training programs, including:

ESSO-certified HIPEC surgery course in Hamburg, Germany

Microwave liver ablation training in Reims, France

NanoKnife (irreversible electroporation) training at King’s College, London

In 2019, he further expanded his expertise through advanced surgical oncology training at Memorial Sloan Kettering Cancer Center, New York, USA.

Clinical Expertise & Procedures

Cytoreductive surgery with HIPEC

Resection of abdominal wall metastases

Minimally invasive and laparoscopic surgery

General and gastrointestinal surgery

Colorectal surgery

Laparoscopic cholecystectomy

Abdominal surgery

Surgical oncology

NanoKnife (irreversible electroporation)

Laparotomy

Current Position

Attending Surgeon, Department of General and Oncological Surgery (Surgery C)

Education & Surgical Training

MD (with honors), Semmelweis University Medical School, Hungary

Cardiothoracic Surgery Training, Sheba Medical Center

General Surgery Training, Montefiore Medical Center (Einstein Campus), New York, USA

General Surgery Training, Rabin Medical Center (Beilinson Campus), Israel

Board Certifications

General Surgery

Surgical Oncology

Selected Publications

Correlation Between Intraoperative and Pathological Findings in Patients Undergoing CRS and HIPEC

Berger Y, Jacoby H, Kaufmann MI, Ben-Yaacov A, et al.

Laparoscopic vs Open Hartmann’s Reversal: A Decade-Long Multicenter Retrospective Study

Horesh N, Lessing Y, Rudnicki Y, Ben-Yaacov A, et al.

Readmission Rates and Risk Factors Following CRS and HIPEC for Peritoneal Surface Malignancies

Dreznik Y, Hoffman A, Hamburger T, Ben-Yaacov A, et al.

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Department:

Gastrointestinal Cancer Department

Specialties:

Internal Medicine, Medical Oncology, Cancer Epidemiology

Prof. Ben Boursi is a leading specialist in Internal Medicine, Medical Oncology, and Radiotherapy at Sheba Medical Center. He earned his medical degree with distinction (cum laude) from the School of Medicine at Tel Aviv University.

He completed his residency in Internal Medicine at Sourasky Medical Center in Tel Aviv, followed by advanced subspecialty training in Gastrointestinal Oncology and Cancer Epidemiology at the University of Pennsylvania, USA.

Academic and Research Appointments

Prof. Boursi holds an academic position within the Department of Epidemiology and Preventive Medicine at the School of Medicine, Tel Aviv University. In addition, he serves as an Associate Scholar at the Perelman School of Medicine, University of Pennsylvania.

Research and Scientific Contributions

Prof. Boursi’s research is centered on developing innovative therapeutic approaches in oncology, with a particular focus on the role of the microbiome in cancer development and treatment response.

He is internationally recognized as a leader in microbial modulation in cancer therapy and founded the ECOG-ACRIN Microbiome Working Group. His work has been published in leading scientific journals, including Science, and presented at major global oncology conferences, as well as featured in ASCO educational platforms and podcasts.

Alongside his research, Prof. Boursi is actively involved in academic teaching, delivering lectures on host–microbiome interactions at Tel Aviv University and Bar-Ilan University.

His research also extends to cancer prevention and early detection. He has developed predictive models for early diagnosis of colorectal and pancreatic cancers, which are currently undergoing clinical evaluation.

Clinical Expertise

Gastrointestinal oncology

Current Position

Physician, Gastrointestinal Cancer Department

Education and Training

B.Med.Sc (Summa cum laude), School of Medicine, Tel Aviv University

MD (Magna cum laude), School of Medicine, Tel Aviv University

Clinical and Research Fellowship in Gastrointestinal Oncology and Cancer Epidemiology, Perelman School of Medicine, University of Pennsylvania

Elective Training in Medical Oncology, MD Anderson Cancer Center

Elective Training in Medical Oncology, Mayo Clinic

Advanced Research Training, Weizmann Institute of Science

Board Certifications

Internal Medicine

Medical Oncology

Professional Memberships

Israeli Association of Clinical Oncology and Radiotherapy (ISCORT)

American Society for Cancer Research

Selected Publications

Immune-related adverse events as predictors of durable response to BRAF inhibitors in metastatic melanoma with BRAF V600 mutation

Ben-Betzalel G, Baruch EN, Boursi B, et al.

Re-evaluating the IDEA classification: Novel predictive and prognostic markers in stage III colon cancer

Margalit O, Mamtani R, Yang YX, Boursi B, et al.

Prognostic significance of carcinoembryonic antigen (CEA) levels in stage I–II colon cancer

Margalit O, Mamtani R, Yang YX, Boursi B, et al

Dr. Alexander Beny is a Oncologist at the Rambam Medical Center who is Board Certified in Oncology and speaks English and Hebrew. He has extensive experience and education in the field and is available for contact at the hospital.

Dr. Tamar Jablonski-Perec is an oncologist at Hadassah Medical Center in Jerusalem. She holds a Doctor of Medical Sciences from the Hebrew University and has experience from the renowned Sloan-Kettering Cancer Center in New York. She is the Head of Institute of Oncology, Head of Breast Cancer Treatment Center, and Professor of the Department of Oncology at the Hebrew University. She is a member of several international cancer communities and was awarded a scholarship from the Hadassah Medical School.